The Hematology/Oncology Fellowship at Tower/Health McGlinn Cancer Institute is a three-year, ACGME-accredited program. There are currently 2 fellows year each with potential plans of growing to 3 fellows per year.  The program was a combined program with Jefferson for 4 years before becoming a free-standing fellowship in July 2020.

Outpatient and Inpatient rotations offered at Reading Hospital and McGlinn Cancer Center.

At Reading Hospital and the McGlinn Cancer Institute, there is exposure to the wide range of hematologic and oncologic diseases.  The Reading Hospital oncology program sees more than 1,500 new cancer diagnoses per year as well as over 1000 referrals of benign and hematologic malignancy cases. There are over 20 tumor boards each month and regular multidisciplinary clinics including breast, lung, gyn, GU and GI malignancy. There is an active clinical research program that enrolls more than 100 patients/year on clinical trials and registries. There is a mixture of socioeconomic and ethnic groups cared for at the hospital and clinic.

Reading is the county seat of Berks County in southeastern Pennsylvania. The city population is just under 100,000 and the medical community services Berks County with a population of over 400,000. Reading Hospital is nonprofit teaching hospital with over 700 inpatient beds. The hospital has over 120,000 emergency room visits per year an average nearly 20,000 inpatient and outpatient surgical procedures. Reading Hospital serves as the tertiary care center for the six hospital Tower Health network.

Patients referred to the Hematology/Oncology department are made up both primary referrals as well tertiary referrals from the surrounding communities.  That referral pattern provides exposure to unusual and rare cases as well as more common diagnoses that might normally not be referred to a tertiary care setting.  

Clinical experience will include both inpatient and outpatient experience.  The inpatient service includes both primary and consult patients.  The fellow will supervise a team that may include medical residents, students and midlevel providers. The inpatient clinical cases include solid tumor oncology, benign and consultative hematology and thrombosis along with a growing inpatient hematologic malignancy and leukemia service.  Outpatients are seen in the McGlinn Cancer Institute.  Many new referrals are seen through the multi-disciplinary clinics that are run at the center. Weekly multidisciplinary clinics include lung/Pulmonary, breast, GU and GI malignancies. A 40-bed infusion center, GYN Oncology Department, radiation oncology, oncology social work, clinical trials department, risk assessment/genetics department and palliative care department are located at the Cancer Institute.

There is close collaboration and interactions with the 12 Hematology-Oncology faculty including clinics and conferences, mentoring and research opportunities.  The faculty comes from a wide range of background and experiences with fellowship training at Mayo Clinic, Penn State, Jefferson, Drexel/Hahnemann, Harvard, Fox Chase, Walter Reed, University of Arizona and the University of Maryland.  Although all the physicians practice general Hematology and Oncology, many have sub specialized and have large practices in the Hematology and Oncology subspecialties. 

There will be opportunities for collaboration with mid-level practitioners, oncology nurses, oncology nurse navigators, oncology PharmDs and pharmacist, genetics counselors, oncology social workers and research nurses.

There is an active and well-staffed research department in the McGlinn Cancer Center.  Participation in clinical research is encouraged and time has been set aside during the 1st 2 years for research.  A larger portion of the 3rd year has been allotted for involvement and completion of research projects.  Submission of abstracts and participation in national meetings is encouraged.

At the Reading Hospital Campus, there is a dynamic educational environment with multiple primary residencies and subspecialty fellowship programs. Additional medical fellowships are available in Cardiology, Gastroenterology, Pulmonary Critical Care Medicine, Endocrinology and Infectious Disease. The Tower Health campus of Drexel University College of Medicine will open in 2021 offering undergraduate training.

Tower health hematology Oncology fellowship is associated with the Sidney Kimmel Cancer Center at Thomas Jefferson University in Philadelphia.  Rotations at Jefferson include experience on the inpatient stem cell transplant and leukemia unit as well as on the outpatient hemostasis, thrombosis and hemophilia service.  Additional electives are available at Jefferson and elsewhere.

The Jefferson Sidney Kimmel Cancer Center is an NCI designated Cancer Center with a hemopoietic stem-cell transplant program, leukemia/lymphoma service, well-developed multi-disciplinary teams and one of the most established general hematology training programs in the country. Jefferson is a 1,000 bed urban hospital in Philadelphia with an active educational environment for trainees.

The mission of the Reading/ McGlinn Cancer Institute Center Hematology/Medical Oncology Fellowship Program is to provide fellows with a supervised training experience at the level required for the fellows to acquire competency as a specialist in the combined fields of hematology and medical oncology.

It is the goal of the program that graduates obtain the professional, cognitive and technical skills to provide competent, compassionate care.  Fellows will have the opportunity to practice patient communication and shared decision making and will learn to apply current evidence-based knowledge relevant to patient care. Clinical training is achieved through a balance of clinical experience, self-directed learning, didactic sessions as well as active mentoring. Fellows will have ample time and be encouraged to be involved in research activities.